Sekiya T, Takeya T, Brown E L, Belagaje R, Contreras R, Fritz H J, Gait M J, Lees R G, Ryan M J, Khorana H G, Norris K E
J Biol Chem. 1979 Jul 10;254(13):5787-801.
The total synthesis of a 207-base pair-long DNA, which is biologically functional as a tyrosine suppressor transfer RNA gene, has been completed. The synthesis involved the enzymatic joining of the previously synthesized duplexes. Thus, the duplex corresponding to the promoter region [P] (Sekiya, T., Brown, E.L., Ramamoorthy, B., Fritz, H.-J., Gait, M.J., Lees, R.G., Ryan, M.J., Khorana, H.G., and Norris, K.E. (1979) J. Biol. Chem. 254, 5781-5786) was jointed to Duplex [I] (Caruthers, M.H., Kleppe, R., Kleppe, K., and Khorana, H.G. (1976) J. Biol Chem. 251, 658-666) to form [P + I]. Separatively, Duplex [III + IV + Vb] was prepared from the previously described Duplexes [III], [IV], and [Vb]. (Loewen, P.C., Miller, R.C., Panet, A., Sekiya, T., and Khorana, H.G. (1976) J. Biol. Chem. 251, 642-650; Sekiya, T., Besmer, P., Takeya, T., and Khorana, H.G. 1976) J. Biol. Chem. 251, 634-641; Ramamoorthy, B., Lees, R.G., Kleid, D., and Khorana, H.G., (1976) J. Biol Chem. 251, 676-694). The product [P + I], was joined to Duplex [II] (Panet, A., Kleppe, R., Kleppe, K., and Khorana, H.G. (1976) J. Biol. Chem. 251, 651-657) and then to [III + IV + Vb] without isolation of the intermediates. In all the above joinings, the duplexes carried 32P-labeled phosphate groups at the appropriate 5'-ends. The total DNA and the intermediate duplexes were all characterized by their relative mobilities in electrophoresis on polyacrylamide gel slabs, by nearest neighbor analysis, and by degradation to 5'-nucleotides of radioactively labeled joined products. Two succeeding papers describe the transcription in vitro and the suppressor activity in vivo, of the synthetic gene now described.
已完成一个207个碱基对长的DNA的全合成,该DNA作为酪氨酸抑制性转移RNA基因具有生物学功能。合成过程涉及将先前合成的双链体进行酶促连接。因此,与启动子区域[P]对应的双链体(关谷,T.,布朗,E.L.,拉马穆尔蒂,B.,弗里茨,H.-J.,盖特,M.J.,利斯,R.G.,瑞安,M.J.,霍拉纳,H.G.,和诺里斯,K.E.(1979)《生物化学杂志》254,5781 - 5786)与双链体[I](卡拉瑟斯,M.H.,克莱佩,R.,克莱佩,K.,和霍拉纳,H.G.(1976)《生物化学杂志》251,658 - 666)连接形成[P + I]。另外,双链体[III + IV + Vb]由先前描述的双链体[III]、[IV]和[Vb]制备而成。(洛文,P.C.,米勒,R.C.,帕内特,A.,关谷,T.,和霍拉纳,H.G.(1976)《生物化学杂志》251,642 - 650;关谷,T.,贝斯默,P.,竹谷,T.,和霍拉纳,H.G. 1976)《生物化学杂志》251,634 - 641;拉马穆尔蒂,B.,利斯,R.G.,克莱德,D.,和霍拉纳,H.G.,(1976)《生物化学杂志》251,676 - 694)。产物[P + I]与双链体[II](帕内特,A.,克莱佩,R.,克莱佩,K.,和霍拉纳,H.G.(1976)《生物化学杂志》251,651 - 657)连接,然后在不分离中间体的情况下与[III + IV + Vb]连接。在上述所有连接中,双链体在适当的5'-末端带有32P标记的磷酸基团。总DNA和中间双链体均通过它们在聚丙烯酰胺凝胶平板上电泳的相对迁移率、最近邻分析以及对放射性标记连接产物降解为5'-核苷酸来表征。随后的两篇论文描述了现在所描述的合成基因的体外转录和体内抑制活性。